Description
Miglustat acts as a competitive inhibitor of the enzyme glucosylceramide synthase. By reducing the synthesis of glycosphingolipids, it aims to mitigate the toxic accumulation of GM2 ganglioside in the nervous system.
User Reviews
Log in to leave a review.
No reviews yet for this remedy.